Johnson & Johnson Celebrates 30th Anniversary of CARTO 3D Electrophysiology Navigation System, Driving Iterative Breakthroughs in Ablation Therapy

China Finance and Economics Network, July 4th — During the 23rd Atrial Fibrillation Academic Conference, Johnson & Johnson Medical Technologies celebrated the 30th anniversary of the CARTO 3D Electrophysiology Navigation System with the theme "CARTO Thirty Years, Innovating Together". A preview documentary with the same theme was released, which narrated the remarkable achievements in China's atrial fibrillation treatment over the past thirty years from the perspective of local surgeons.

"Through thirty years of unwavering dedication, we have left a solid footprint in China's electrophysiology field. This is not only the thirty years of CARTO but also the thirty years of remarkable advancements in China's atrial fibrillation treatment technology. It is an immense honor to be both a witness and beneficiary of this journey," said Li Miao, Vice President of the Cardiac Electrophysiology Division at Johnson & Johnson Medical (China) Ltd. Standing at the new starting point of this thirty-year milestone, the company will continue to deepen its commitment to the Chinese market, accelerate the introduction of more groundbreaking solutions, and provide advanced and high-quality treatment options for countless patients with atrial fibrillation, enabling more people to regain healthy heartbeats.

According to reports, since the debut of CARTO in 1995, the application of cardiac three-dimensional mapping systems represented by CARTO has marked the official entry of electrophysiology into the three-dimensional era. From supraventricular tachycardia to the interventional diagnosis and catheter-based radiofrequency ablation treatment of various complex rapid arrhythmias, mapping technologies dominated by three-dimensional anatomical mapping systems have not only deepened the clinical understanding of arrhythmia diseases and improved surgical success rates, but also helped reduce complications and significantly minimized damage caused by X-rays. Additionally, three-dimensional anatomical imaging of the heart can avoid critical cardiac structures, reducing surgical risks; more importantly, it can integrate electrophysiological data with three-dimensional anatomical information, revealing arrhythmia mechanisms and targets, guiding catheter ablation, enhancing ablation efficacy, and shortening operation time.

Empowered by the CARTO system, Johnson & Johnson Medical Technologies has gradually introduced technical solutions and innovative concepts such as contact force monitoring and quantified ablation, high-precision mapping, green electrophysiology, and pulsed radiofrequency multi-energy ablation.

The development history of the CARTO 3D electrophysiology navigation system is also an industry development history that reflects deep collaboration and co-growth with Chinese electrophysiologists. To help cultivate more professionals in the electrophysiology field, Johnson & Johnson Medical Technology also organizes specialized training aimed at accelerating the growth curve of practitioners by providing a more efficient and comprehensive immersive medical technology experience, enabling them to become qualified and excellent electrophysiologists more quickly.